Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
Van Gulck E, Vlieghe E, Vekemans M, Van Tendeloo VF, Van De Velde A, Smits E, Anguille S, Cools N, Goossens H, Mertens L, De Haes W, Wong J, Florence E, Vanham G, Berneman ZN.
AIDS. 2012 Feb 20;26(4):F1-12.
Related citations
Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials.
O'Hagan JJ, Hernán MA, Walensky RP, Lipsitch M.
AIDS. 2012 Jan 14;26(2):123-6. No abstract available.
High-level, lasting antiviral immunity induced by a bimodal AIDS vaccine and boosted by live-virus exposure: prevention of viremia.
Rasmussen RA, Siddappa NB, Lakhashe SK, Watkins J, Villinger F, Ibegbu C, Florese RH, Robert-Guroff M, Montefiori DC, Forthal DN, O'Connor D, Ruprecht RM; Clade C Program Project Group.
AIDS. 2012 Jan 14;26(2):149-55.
Effect of therapeutic HIV recombinant poxvirus vaccines on the size of the resting CD4+ T-cell latent HIV reservoir.
Persaud D, Luzuriaga K, Ziemniak C, Muresan P, Greenough T, Fenton T, Blackford A, Ferguson K, Neu N, Cunningham CK.
AIDS. 2011 Nov 28;25(18):2227-34.
Impaired Bacillus Calmette-Guérin cellular immune response in HIV-exposed, uninfected infants.
Mazzola TN, da Silva MT, Abramczuk BM, Moreno YM, Lima SC, Zorzeto TQ, Passeto AS, Vilela MM.
AIDS. 2011 Nov 13;25(17):2079-87.
Delay of simian human immunodeficiency virus infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicide.
Cheng-Mayer C, Huang Y, Gettie A, Tsai L, Ren W, Shakirzyanova M, Sina ST, Trunova N, Blanchard J, Jenkins LM, Lo Y, Schito ML, Appella E.
AIDS. 2011 Sep 24;25(15):1833-41.
Selection of human anti-HIV broadly neutralizing antibodies occurs within the context of frozen 1F7-idiotypic repertoire.
Parsons MS, Rouleau D, Routy JP, LeBlanc R, Grant MD, Bernard NF.
AIDS. 2011 Jun 19;25(10):1249-64.
Reactivity profiles of broadly neutralizing anti-HIV-1 antibodies are distinct from those of pathogenic autoantibodies.
Singh H, Henry KA, Wu SS, Chruscinski A, Utz PJ, Scott JK.
AIDS. 2011 Jun 19;25(10):1247-57.
Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability.
Althoff KN, Eichelberger M, Gange SJ, Sharp GB, Gao J, Glesby MJ, Young M, Greenblatt RM, French AL, Villacres MC, Minkoff H.
AIDS. 2011 Jun 1;25(9):1229-32.
Reduced immunogenicity of influenza vaccines in HIV-infected compared with uninfected pregnant women is associated with regulatory T cells.
Richardson K, Weinberg A.
AIDS. 2011 Mar 13;25(5):595-602.
A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune.
Angel JB, Routy JP, Tremblay C, Ayers D, Woods R, Singer J, Bernard N, Kovacs C, Smaill F, Gurunathan S, Sekaly RP.
AIDS. 2011 Mar 27;25(6):731-9.
Vaccinogenicity.
Hanson CV.
AIDS. 2011 Mar 13;25(5):581-4. No abstract available.
The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis.
Nunes MC, von Gottberg A, de Gouveia L, Cohen C, Moore DP, Klugman KP, Madhi SA.
AIDS. 2011 Feb 20;25(4):453-62.
Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control study.
Curlin ME, Cassis-Ghavami F, Magaret AS, Spies GA, Duerr A, Celum CL, Sanchez JL, Margolick JB, Detels R, McElrath MJ, Corey L.
AIDS. 2011 Jan 14;25(2):153-8.
Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptides.
Kran AM, Jonassen TO, Sommerfelt MA, Løvgården G, Sørensen B, Kvale D.
AIDS. 2010 Nov 13;24(17):2609-18.
Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: a Spanish multicenter study.
Riera M, Payeras A, Marcos MA, Viasus D, Farinas MC, Segura F, Torre-Cisneros J, Martín-Quirós A, Rodríguez-Baño J, Vila J, Cordero E, Carratalà J.
AIDS. 2010 Oct 23;24(16):2461-7.
Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization.
Cohen AL, Harrison LH, Farley MM, Reingold AL, Hadler J, Schaffner W, Lynfield R, Thomas AR, Campsmith M, Li J, Schuchat A, Moore MR; Active Bacterial Core Surveillance Team.
AIDS. 2010 Sep 10;24(14):2253-62.
Preventing influenza coinfection among HIV-infected persons: a complex picture coming into focus.
Reyes-Teran G, Butera ST.
AIDS. 2010 Sep 10;24(14):2283-5. No abstract available.
Circumcision status and HIV infection among MSM: reanalysis of a Phase III HIV vaccine clinical trial.
Gust DA, Wiegand RE, Kretsinger K, Sansom S, Kilmarx PH, Bartholow BN, Chen RT.
AIDS. 2010 May 15;24(8):1135-43.
Adenovirus 5 serotype vector-specific immunity and HIV-1 infection: a tale of T cells and antibodies.
D'Souza MP, Frahm N.
AIDS. 2010 Mar 27;24(6):803-9. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on